Viruses for Novel Biomaterials
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 13644
2. Ivanovsky Institute of Virology, National Research Center of Epidemiology and Microbiology, N.F. Gamaleya of the Russian Ministry of Health, 123098 Moscow, Russia
Interests: bionanotechnology; virology; immunology
Special Issues, Collections and Topics in MDPI journals
Currently, investigating viruses is of great importance due to the ongoing COVID-19 pandemic as well as simultaneous and consecutive co-infections with viruses and bacteria, antibody-dependent enhancement (ADE) of viral infections in previously infected or vaccinated hosts, and bionanotechnological platforms for novel biomaterials with target delivery, high penetration into certain types of cells, natural ways of intracellular distribution, and biodegradation. Therefore, an enormous diversity of viruses, approximately~1030, is at the forefront of basic and applied interdisciplinary research, epidemiology, vaccinology, and clinical diagnostics.
Further research of molecular evolution and rearrangements of quasispecies of RNA- and DNA-containing viruses, the possible integration of viral genomic DNA into cellular chromosomes and mitochondrial DNA, innate and adaptive immune responses during natural infection and after vaccination, the interaction of viral factors with the host immune system and cellular proteins, and the evaluation of currently available vaccines against new viral threats are necessary for the possible implementation in bionanotechnology, vaccinology, drug design, and the development of diagnostic systems for acute and chronic infections.
This Special Issue, “Viruses for Novel Biomaterials”, will include selected research and review articles describing mechanisms of virus adaptation to their hosts, factors of innate and adaptive immunity, and the possible implementation of attenuated viruses in nanotechnology.
Dr. Olga V. Morozova
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular evolution of virus quasispecies
- innate resistance and virus-specific immune response
- new approaches for vaccine design
- detection of novel and re-emerging viral infections
- biosafety of implementation of viruses in bionanotechnology